Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus.
Methicillin resistance in Staphylococcus aureus depends on the production of mecA, which encodes penicillin-binding protein 2A (PBP2A), an acquired peptidoglycan transpeptidase (TP) with reduced susceptibility to β-lactam antibiotics. PBP2A cross-links nascent peptidoglycan when the native TPs are inhibited by β-lactams. Although mecA expression is essential for β-lactam resistance, it is not sufficient. Here we show that blocking the expression of wall teichoic acids (WTAs) by inhibiting the first enzyme in the pathway, TarO, sensitizes methicillin-resistant S. aureus (MRSA) strains to β-lactams even though the β-lactam-resistant transpeptidase, PBP2A, is still expressed. The dramatic synergy between TarO inhibitors and β-lactams is noteworthy not simply because strategies to overcome MRSA are desperately needed but because neither TarO nor the activities of the native TPs are essential in MRSA strains. The "synthetic lethality" of inhibiting TarO and the native TPs suggests a functional connection between ongoing WTA expression and peptidoglycan assembly in S. aureus. Indeed, transmission electron microscopy shows that S. aureus cells blocked in WTA synthesis have extensive defects in septation and cell separation, indicating dysregulated cell wall assembly and degradation. Our studies imply that WTAs play a fundamental role in S. aureus cell division and raise the possibility that synthetic lethal compound combinations may have therapeutic utility for overcoming antibiotic-resistant bacterial infections.
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, United States.
Jennifer
J
Campbell
Atul K
AK
Singh
John P
JP
Santa Maria
Younghoon
Y
Kim
Stephanie
S
Brown
Jonathan G
JG
Swoboda
Eleftherios
E
Mylonakis
Brian J
BJ
Wilkinson
Suzanne
S
Walker
D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology; D002473:Cell Wall / Q000737:chemistry / Q000378:metabolism; D031060:Colocasia / Q000201:enzymology; D016106:Methicillin Resistance; D055624:Methicillin-Resistant Staphylococcus aureus / Q000378:metabolism*; D046915:Penicillin-Binding Proteins / Q000378:metabolism; D010457:Peptidoglycan / Q000096:biosynthesis*; D010458:Peptidyl Transferases / Q000378:metabolism*; D013682:Teichoic Acids / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D014415:Tunicamycin / Q000037:antagonists & inhibitors; D047090:beta-Lactams / Q000037:antagonists & inhibitors
D000900:Anti-Bacterial Agents; D046915:Penicillin-Binding Proteins; D010457:Peptidoglycan; D013682:Teichoic Acids; D047090:beta-Lactams; D014415:Tunicamycin; D010458:Peptidyl Transferases